LANTERN Phase III Supports Nasal Photodisinfection Before Surgery
Ondine Biomedical reported that the 5,188-patient Phase III LANTERN trial met its prespecified primary endpoint: adding a single preoperative nasal photodisinfection procedure to standard care produced an estimated 40.5% reduction in 30-day surgical-site-infection risk….
